Review

Prostate Cancer and Prostatic Diseases (2005) 8, 133–139. doi:10.1038/sj.pcan.4500781 Published online 15 February 2005

Nerve-sparing radical retropubic prostatectomy: techniques and clinical considerations

P Gontero1,2 and R S Kirby1,2

  1. 1Clinica Urologica, Università del Piemonte Orientale, Novara, Italy
  2. 2St Georges Hospital, London, UK

Correspondence: P Gontero, Clinica Urologica, Dipartimento di Scienze Mediche, Università del Piemonte Orientale, Via Solaroli, 17, 28100 Novara, Italy. E-mail: paolo.gontero@med.unipmn.it

Received 19 August 2004; Revised 1 November 2004; Accepted 1 December 2004; Published online 15 February 2005.

Top

Abstract

There are essentially two ways to accomplish nerve preservation during radical retropubic prostatectomy: the 'apical approach' described by Walsh and the so-called 'lateral approach', a simplified method where the dissection is initially conducted on the portion of the bundles that courses posterolateral to the prostate. Do the different techniques differ in the ability to preserve potency and in the positive surgical margins rate? No previous study has addressed this question. Above all, the preoperative and intraoperative indications to spare or not the nerves remain a matter of debate. The present review is an attempt to elucidate these questions in light of the current literature.

Keywords:

radical prostatectomy, nerve-sparing, techniques, surgical margins, erectile dysfunction

Top

Anatomical location of the neurovascular bundles

A precise knowledge of the neurovascular anatomy of the prostate is an essential prerequisite for a nerve-sparing (NS) approach to radical retropubic prostatectomy. This has been excellently refined in cadaveric studies by Walsh and co-workers.1, 2

The neurovascular bundles (NVB) that course posterolateral to the prostate consist of a complex structure related to the vascularization of the outer prostatic portion and to the innervation of the prostate, urethra and corpora cavernosa. Small arterial branches originating from the inferior vesical artery and venous vessels draining in the homonymous vein constitute the vascular portion of the bundles. They run in the lateral pelvic fascia, medially to the cavernosal nerve branches (vide infra) to terminate as capsular vessels that pierce the prostatic fascia. These vessels are important when performing an NS radical retropubic prostatectomy (RRP) as they provide the landmark for the identification of the nerves.

The caudal portion of the pelvic plexus, located at the tip of the seminal vesicles, emanates autonomic fibres, which form a dense network with the described vessels.3, 4 Some of them perforate the prostatic capsula to enter the substance of the prostatic gland. These branches are inevitably sacrificed during an NS approach, but it is believed that they do not contribute significantly to erectile function. The majority of nerve fibres, known as the cavernous branches, travel in a direct route from the pelvic plexus towards the posterolateral base of the prostate, gradually coalescing from a group of fibres approximately 12 mm wide to a more organized bundle approximately 6 mm wide at the level of the prostate. At this point, they lie just underneath the lateral pelvic fascia, between the levator fascia and the prostatic fascia (a fibrous layer in direct continuity with the true prostatic capsule). At the level of the membranous urethra, they are located at the 3 o'clock and 9 o'clock position, just beneath the striated sphincter that at this point surrounds both the urethra and the prostatic apex.

Top

Techniques of NS surgery during RRP

Two main surgical approaches to an NSRRP have been described.5 In the so-called 'anatomical technique', first reported by Walsh,2, 6, 7 the nerves dissection is initiated at the apical level with primary isolation of the urethra. Ruckle and Zincke8 have proposed an alternative technique where the neurovascular bundles are primarily dissected off the lateral prostate and only subsequently is the urethra transected. Several variants of this lateral approach to the neurovascular bundles have been subsequently described.9, 10, 11

The apical approach to the NVB (the 'Walsh technique')7

There are a number of key steps in this technique that, if overlooked, may jeopardize the success of nerve preservation. For each of them, PC Walsh has provided useful tips to avoid inadvertent nerve injury during surgery. These are summarized below:

  1. After division of the dorsal vein complex, the proximal vein edges on the anterior surface of the prostate need to be sutured in order to avoid back bleeding. This should be accomplished with a running V-shaped suture rather than trying to tie together the edges towards the midline. The latter manoeuvre may displace medially the bundles towards the anterior prostate, making their accurate dissection more difficult.
  2. A critical point where the bundles may be damaged is during the transection of the urethra and the surrounding striated sphincter musculature. As the neurovascular bundle when approaching the prostatic apex is located underneath the sphincter and can be fixated into a medial position by an apical vessel, care should be used to transect only the lateral edges of the sphincter at the urethral level, refraining from any dissection underneath the prostatic apex.
  3. In order to avoid excessive traction while releasing the bundles from the lateral prostatic surface, after the urethra has been transected the catheter should be removed and the dissection carried out while the prostate is rolled from side to side.
  4. By releasing the superficial layer of the lateral pelvic fascia, the prostate becomes more mobile and the neurovascular bundles move laterally. This manoeuvre is best accomplished by lifting up the prostatic fascia with a right angle clamp starting at the bladder neck and proceeding down to the apex. At this point, a groove will appear on the posterolateral edge of the prostate as a landmark for the neurovascular bundle which is located just laterally to it. Following the groove down to the apex will enable the identification of the bundles at the level of the transected urethra: only at this point, can the dissection be completed at the apex and carried out posteriorly to develop the prostatic–rectal plane without damaging the nerves.
  5. The bundles can now be released completely from the prostate with gentle spreading of a right angle from the apex up to the midportion of the prostate. Some vessels that pierce the prostate at this level may prevent the release of the bundle and need to be divided with small hemoclips. Avoidance of unipolar electrocoagulation is of paramount importance for the maintenance of the integrity of the nerves.
  6. The division of a small arterial vessel running from the neurovascular bundle, over the seminal vesicle to supply the prostatic base, usually enables the bundles to be completely freed from the prostate.
  7. The last critical point for a successful NS technique is represented by the dissection of the seminal vesicles. As the midportion of the pelvic plexus is anatomically located at the tip of the seminal vesicles, the dissection of these small organs must be carried out very carefully, particularly in the lateral aspect, where small arterial branches are often encountered and need to be clipped close to the seminal vesicles.

The lateral approach to the NVB

The Ruckle and Zincke8 technique
 

This technique represents an alternative and simplified anatomical approach in which the dissection of the neurovascular bundles off the prostate precedes the apical dissection and the urethral transection. Briefly, after blunt perforation of the lateral prostatic fascia bilaterally, the dorsal vein complex is transected in between a double ligation with the creation of an oval defect in the dorsal prostatic fascia.12 A vertical incision in the prostatic fascia is then conducted from one of the two lateral sides of the defect (for example, the left) down to just above the left neurovascular bundle. From that point, the incision is extended superiorly towards the bladder and inferiorly towards the urethra parallel to the neurovascular bundle. Overall the incision, if carried out in the left side, will appear as an upside down T to the operator positioned on the left side of the patient. By placing the index finger at the confluence of the incisions in the prostatic fascia, the left neurovascular bundle is swept laterally from the prostate. A posterior prostatic plane is then created by advancing the finger between the two layers of the Denonvillier fascia: the anterior layer, attached to the posterior prostate, and the posterior one in contact with the rectum. The finger is further advanced until it reaches the lateral prostatic fascia of the controlateral right side. The fascia is then perforated and spread with a right angle clamp medially to the right neurovascular bundle. This manoeuvre enables the right bundle to be freed from the prostate.

The Scardino technique13, 14
 

In this technique, following the transection of the dorsal complex, the lateral pelvic fascia is incised medial to the neurovascular bundle on the anterolateral prostatic portion and the bundles are gently swept laterally from the prostate. A lateral retraction of the bundle allows the Denonvillier fascia to be exposed. An incision is made on the posterior Denonvillier fascia that covers the prerectal fat. Care must be taken to preserve Denonvillier's fascia over the posterior prostate in order to reduce the risk of positive surgical margins (PSM).

The Klein et al9 variant technique
 

The authors describe their NS technique as a modification of the initial dissection of the perirectal lateral pelvic fascia reported by Stephenson et al15 in a non-NS surgical approach of RRP. In a way conceptually similar to that of Ruckle and Zincke8 and Scardino,13, 14 the incision of the lateral pelvic fascia along the longitudinal axis of the prostate begins at a level well medial to the neurovascular bundles. The bundles are then swept inferiorly and laterally from the prostate and then sharply dissected free from the prostate from apex to base. When the bundles have been completely freed on both sides, the plane between the posterior prostate and the anterior rectum is developed with blunt dissection rotating the prostate from side to side. Only at this point are the dorsal vein and the urethra divided.

Top

Do the different NS techniques differ in outcomes?

The surgeon considering an NSRRP must balance the need for complete eradication of local tumour with the preservation of sexual function. A successful NS technique should combine a high probability of potency recovery with a low PSM rate, particularly at the apex and the posterolateral prostate. Extensive literature has demonstrated that PSM adversely affect recurrence-free survival outcome after surgery.16, 17, 18, 19 A PSM is defined by the majority of authors as the extension of the tumour to the inked surface of the resected specimen and is considered an indicator of incomplete excision of the neoplasm.20, 21

As the cavernosal nerves cannot always be visualized on the dorsolateral prostate surface, Walsh7 advises their identification at the prostatourethral junction after dissecting the apex of the prostate. On the contrary, the supporters of the lateral approach to the bundles contend that identifying the nerves at the apex is more difficult.8 Are these different approaches equally safe in terms of cancer control?

Ruckle and Zincke8 compared 104 consecutive patients who had undergone the original Walsh NS RRP before 1991 with 123 consecutive patients who had an NS procedure according to their modified technique after 1991. The PSM rate (32% in the Walsh technique vs 37% in the Ruckle and Zincke technique) did not significantly differ in the two groups. In a similar comparative study, Klein et al9 reported a reduction in PSM from 33.3% employing the Walsh technique to 15.5% when their modified lateral approach to the bundles was used. However, these retrospective analyses are biased by potential confounds such as stage migration, improvement in preoperative selection criteria and surgical expertise.

As far as sexual preservation is concerned, no study as yet has compared the degree of potency recovery among the different reported NS techniques. Outstanding postoperative potency rates varying from 86 to 62% have been reported employing the Walsh NS technique, but these seem to be confined only in centres of excellence.22, 23 The success rate of the procedure drops to 44% in a large retrospective survey of nonspecialists24 and falls to 21% in a single institutional prospective series assessing preoperative and postoperative outcomes with validated questionnaires.25

Several factors may account for these discrepancies. Firstly, age and preoperative sexual functioning have been recognized as independent predictors of postoperative recovery of erectile function.26 The chances of potency recovery decrease with the increase of age at time of the operation. The excellent results in the series of Walsh refer mainly to patients younger than 65 y.27 Noh et al28 reported that all patients younger than 50 y in his series regained postoperative sexual function compared with only 38% older than 70 y. Similarly, patients with some degree of erectile dysfunction prior to the procedure are more likely to develop severe erectile dysfunction postoperatively.29 Another key factor is the timing for potency recovery. At 3 months postoperatively, only 38% of patients in the Walsh series were able to perform unassisted sexual intercourse, whereas potency had been regained by 86% at 18 months.30 Whether the patient decides or not to undertake early postoperative pharmacological prophylaxis may have an additional impact on the subsequent recovery of erectile function.31, 32, 33 Monolateral NS negatively affects potency recovery.34 At least a 25% reduction in success rate is expected if only one neurovascular bundle can be spared at the time of surgery.26

Finally, poor outcomes of an NSRRP may simply be the result of a suboptimal performance of the surgical technique. Recently, Walsh et al30 reviewed the videotapes of 62 of his own NSRRP. Patient's reported potency rates were correlated with four specific steps of the procedure deemed to be crucial for a correct nerve preservation, namely, V-shaped oversewing of the back bleeders from the proximal dorsal vein on the anterior surface of the prostate, maintenance of a collar of striated sphincter lateral to the urethra while placing the sutures, division of the posterior striated sphincter at its midpoint between the apex and the urethral stump and achievement of excellent hemostasis at the end of the case. Notably, in all eight cases who failed to regain potency at 18 months, the technique was judged blindly as less than optimal for all the four steps described above.

Given the complex series of variables that can interfere with the success of a sexual sparing RRP, it has to be concluded that, out of a randomized prospective fashion, a comparison of potency outcomes for the different techniques of NSRRP may be an impossible task. No such study is at the moment available in the literature.

Top

Indications for sparing or not sparing the neurovascular bundles

Preoperative indications

The majority of authors agrees that the ideal candidate for an NSRRP should be fully potent preoperatively and have an organ-confined cancer, that is, a clinical T1/T2a and T2b disease.20 As the neurovascular bundles lie outside the capsule and fascia of the prostate, cancer control is not compromised by an NS procedure when the tumour is organ confined.

T1a and T1b are ideal for NS as they rarely invade the NVB.35 T1c tumours have been reported to have a PSM rate varying from 0 to 59%,36 so eligibility for an NS should be judged according to PSA and Gleason score. T2a and T2b cancers with a controlateral negative biopsy are considered low-volume localized diseases with a high probability to be organ confined.37 Low Gleason score38 and PSA are preferable since high preoperative PSA and biopsy grade increase the risk of extracapsular extension and therefore of PSM.39, 40 As shown in Table 1, a clinical T1 and T2 prostate cancer with a PSA below <10 ng and a Gleason score less than or equal to7 constitute the main eligibility criteria for an NS procedure in the majority of authors. A useful tool to predict the probability of extracapsular tumour extension on the basis of preoperative parameters is represented by the Partin Tables.41 Cheng et al42 found the combination of PSA value and the percentage of cancer in the biopsy specimen to accurately predict the risk for positive margins and propose a model based on these two variables to select the candidates for NSRRP. Tigrani et al43 studied 108 patients who underwent RP and found the number of positive biopsies and not PSA level, Gleason score or primary grade to be the best predictor of margins status.


Others have advocated even more strict inclusion criteria. The neurovascular bundle located on the site of a positive biopsy that contains more than 50% of tumour or perineural invasion or a Gleason 7 or higher tumour should be removed according to Alsikafi and Brendler.44

Several authors have adopted the practice of sparing the nerve only on the site of a negative biopsy.45, 46, 47, 48 By doing so, Huland et al48 found a 0% incidence of PSM on the NS site while 27% of patients had disease in the removed bundle. Similarly, Park et al45 found a 32% rate of extracapsular extension on the site of positive biopsy vs only 7% when the biopsy was negative. The site-specific removal of the neurovascular bundle resulted in a potential reduction of PSM in 50% of patients with extracapsular extension. In the series of Graefen et al,47 the excision of the neurovascular bundle on the side of a positive biopsy excluded approximately 30% of patients from an NSRP unnecessarily, while the overall positive margin rate was 15.9%. The utility of using such strict selection criteria is also questioned by the observation that 78% of patients with unilateral positive biopsies have bilateral tumour involvement at the examination of the entire specimen.37

Walsh49 states that the site of a positive biopsy or of a palpable tumour or the presence of perineural invasion represents strict criteria upon which the decision to excise a neurovascular bundle should be based. A previous study showed that only 17% of patients with perineural invasion had a PSM at the level of the neurovascular bundle.50 Rather, a subjective intraoperative judgment is the most accurate indicator of the necessity to sacrifice the neurovascular bundle.7

Intraoperative indications

Walsh7 recommends to proceed to secondary excision of the NVBs (which should always be spared in the first instance), in the presence of one of the following intraoperative findings:

  1. induration in the lateral pelvic fascia
  2. adherence of the NVB to the prostate while it is being released
  3. inadequate tissue covering the posterolateral surface of the prostate once the prostate has being removed.

Other authors employ the same criteria as intraoperative indicators of wider dissection.51 Alsikafi and Brendler44 advocate wide excision of the neurovascular bundle(s) any time a tumour is palpable on one or both sides intraoperatively, particularly when at the apex. They describe the technique of transecting the anterior urethra 3 mm distal to the apex at all times.44

Some authors have addressed the question of whether obtaining a frozen section of the apical soft tissue during an NSRRP may reduce the incidence of PSM at the prostatic apex, a site often involved in prostate cancer.52 Shah et al53 observed that the routine use of biopsy frozen section of apical soft tissue was responsible for achieving a disease-free status in only 2% of their patients. Other authors,54 questioning the accuracy of preoperative assessment of the tumour extent by digital rectal examination55 and a subjective intraoperative assessment of extracapsular extension,56 decided to spare the bundles after obtaining intraoperative frozen sections in patients with prostate cancer at high risk of extracapsular extension. They reported a PSM rate of 26% and estimated that the frozen sections enabled a 15% reduction of PSM. However, tumour was identified in only 20% of specimens, confirming the finding of previous studies where most patients with positive intraoperative frozen sections did not have detectable tumour in the removed NVB.57

Table 1 lists the indications criteria adopted in some high-volume institutions to decide whether or not to spare the neurovascular bundle(s). The PSM rates should not be taken as an absolute indicator of the validity of the reported criteria since they may largely be influenced by the surgical ability.

Top

Does NS surgery affect the risk of PSM?

Since the surgical boundaries are reduced by performing an NS procedure, this may result in a higher rate of PSM, particularly in the posterolateral prostate. The region of the neurovascular bundle has been shown as the most common site of capsular penetration.15, 61 Using the NS procedure, Catalona and Bigg62 reported that all patients with extracapsular extension in the region of the neurovascular bundle had PSM.

In spite of these premises, it is a fact that, irrespective of the widespread use of an NS approach, the overall rate of PSM has continuously declined over the last two decades.20 A shift in the prostate cancer population towards an intracapsular disease, together with refinements in surgical technique63 and improvement in surgical expertise,64 is the most likely explanation. In the presence of these confounds, it becomes difficult to interpret the potential negative impact of NS procedures.

A few studies have addressed the question of whether NSRRP patients may have an increased risk of PSM. Scardino's group65, 66 documented a further decrease in PSM from 19% in 1989 to 8% in 1993 in spite of the introduction of their lateral approach to the neurovascular bundle. Similarly, earlier reports failed to demonstrate a statistically significant difference in the rate of positive margins between NS and non-NSRRP.67, 68, 69 Overall PSM rates were 24% in NS patients and 31% in NNS ones in the series of Sofer et al.58 The two groups of patients were also equally distributed as regards the incidence of posterolateral margins. Even after adjusting the patients for the major potential prognostic factors the NS status seemed to affect cancer control. In the light of these results, several authors nowadays believe that in appropriately selected patients, the NS approach does not compromise cancer control and that no more than 7% of PSM can be attributed to nerve preservation.70, 71 In the most recent series by Walsh59 of 500 consecutive patients, in which the NVB was widely excised only on one side in 13% of cases, the overall PSM rate was 5%.

Recently, a large multicentric retrospective review of 9035 RPs performed in the last 20 years found the overall PSM rate falling from 40% between 1982 and 1986 to 10% between 1997 and 2002. However, the PSM rate in the pT3 disease population slightly increased between 1997 and 2002, implying that the decrease in surgical margins rates is most likely due to stage migration rather than major improvement in surgical technique.72 Since patients, particularly the pT3 group, were not stratified according to nerve preservation, the potential negative impact of the NS technique remains to be elucidated.

When present, an extensive capsular perforation has been reported to occur in the region of the neurovascular bundles in 87% of cases, resulting in 57% of PSM.65 Negative surgical margins were achieved in 58% of cases after wide excision of the bundles, compared with a 45% rate when both bundles were left intact in a series of 107 patients with posterolateral extensive capsular perforation. Long-term follow-up showed a sustained improvement in disease-free survival for the negative margins patients.73 Park et al45 introduced the concept of the ratio between the PSM rate and the extracapsular extension (ECE) rate to assess the benefit of excising the neurovascular bundle. He found that in series employing more liberal indications for NS the PSM/ECE ratio was higher71 than in those using more conservative NS approaches (68 vs 50).37, 74

A PSM may also be the result of cutting through inside the glandular area of the prostate.75 An NS procedure is expected to carry a higher risk of these 'intraprostatic surgical margins'. Based on the histological review of a large series of NSRRP patients, inadvertent capsular incision during surgery had occurred in no more 2.3% of cases.76 Even if these figures may be too optimistic, literature data have shown intraprostatic surgical margins have little or no effect on oncological outcome.66, 77

These studies, taken together, suggest that NSRRP nowadays does not seem to have a significant impact on prostate cancer control as the majority of patients elected for surgery have an organ-confined disease. Continuous improvement in diagnostic criteria will probably help to better identify those patients with extracapsular extension for whom the preservation of bundles may translate into PSM.

Top

The challenge of the future

The technique of sparing the erigentes nerves during radical prostatectomy was described more than 20 y ago. The operation is currently routinely performed worldwide, but excellent results, particularly for potency preservation, seem to be confined in few centres of excellence. The improvement in cancer control demonstrated by a slight but continuous reduction of the PSM rate over the years has not been accompanied by a similar increase in potency preservation. There is even the suspicion that the better oncological results may simply reflect a stage migration and not an amelioration of the surgical technique.

Will NSRRP outcomes improve in the future? Or will the challenge of improving the results be taken over by new surgical techniques? The first consistent series of NS laparoscopic radical prostatectomy have shown outcomes comparable to open surgery so far.78, 79 A comparative study of open and laparoscopic radical prostatectomy has shown overlapping results for PSM (7.3 vs 7.8%) and potency rates (65 vs 55%).80 As yet we do not know if the laparoscopic technique has reached its zenith or whether it will continue to improve, perhaps with the assistance of the robot. It may be possible that what we have so far described as outcomes of the NSRRP will represent an unsurmountable bar for any sort of surgical approach. If this turns out to be the case, some may even dare to ponder whether the future of prostate cancer cure should be surgical at all.

Top

References

References

1. Schlegel PN & Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol 1987; 138: 1402−1406. | PubMed | ChemPort |
2. Walsh PC & Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 492−497. | PubMed | ISI | ChemPort |
3. Lue TF, Zeineh SJ, Schmidt RA & Tanagho EA. Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol 1984; 131: 273−280. | PubMed | ChemPort |
4. Lepor H et al.. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol 1985; 133: 207−212. | PubMed | ChemPort |
5. Gillitzer R & Thuroff JW. Technical advances in radical retropubic prostatectomy techniques for avoiding complications. Part II: vesico-urethral anastomosis and nerve-sparing prostatectomy. BJU Int 2003; 92: 178−184. | Article | PubMed | ChemPort |
6. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998; 160 6, Part 2: 2418−2424. | Article | PubMed | ChemPort |
7. Walsh PC. Anatomic radical retropubic prostatectomy. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ (eds).Campbell's Urology Vol 4, Chapter 90, 8th edn. WB Saunders Co.: Philadelphia, PA 2002; pp 3107−3129.
8. Ruckle HC & Zincke H. Potency-sparing radical retropubic prostatectomy: a simplified anatomical approach. J Urol 1995; 153: 1875−1877. | Article | PubMed | ChemPort |
9. Klein EA, Kupelian PA, Tuason L & Levin HS. Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy. Urology 1998; 51: 766−773. | Article | PubMed | ChemPort |
10. Jarow JP & Trock BJ. Anatomic radical prostatectomy: does initial dissection of lateral fascia affects outcomes? J Urol 2002; 167 Suppl: A1363.
11. Fernandez S et al.. Experience with water-jet dissection in nerve sparing radical prostatectomy. J Urol 2002; 167 Suppl: A1338.
12. Goldwasser B & Zincke H. Modified Deschamps needle for securing dorsal vein complex and urethra during radical retropubic prostatectomy. Urology 1989; 33: 324−328. | Article | PubMed | ChemPort |
13. Goad JR & Scardino PT. Modifications in the technique of radical prostatectomy to minimize blood loss. Atlas Urol Clin North Am 1994; 2: 65−80.
14. Ohori N & Scardino PT. Localized prostate cancer. Curr Prob Surg 2002; 39: 833−960. | Article |
15. Stephenson RA, Middleton RG & Abbott TM. Wide excision (nonnerve sparing) radical retropubic prostatectomy using an initial perirectal dissection. J Urol 1997; 157: 251−255. | Article | PubMed | ChemPort |
16. Han M et al.. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555−565. | PubMed | ChemPort |
17. Grossfeld GD et al.. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001; 165: 851−856. | Article | PubMed | ChemPort |
18. Kausik SJ et al.. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer 2002; 95: 1215−1219. | Article | PubMed |
19. Epstein JI. Pathologic assessment of the surgical specimen. Urol Clin North Am 2001; 28: 567−594. | PubMed | ISI | ChemPort |
20. Wieder JA & Soloway MS. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol 1998; 160: 299−315. | Article | PubMed | ChemPort |
21. Ohory M et al.. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1992; 148: 331. | PubMed | ISI | ChemPort |
22. Walsh PC. Radical prostatectomy for localised prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 2000; 163: 1802−1807. | Article | PubMed | ChemPort |
23. Catalona WJ & Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150: 905−909. | PubMed | ChemPort |
24. Standford JL et al.. Urinary and sexual function after radical prostatectomy for clinically localised prostate cancer: the prostate cancer outcomes study. JAMA 2000; 283: 354−360. | Article | PubMed | ChemPort |
25. Talcott JA et al.. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997; 89: 1117−1123. | Article | PubMed | ChemPort |
26. Rabbani F et al.. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929−1934. | Article | PubMed | ChemPort |
27. Walsh PC et al.. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58−61. | Article | PubMed | ISI | ChemPort |
28. Noh C, Kshirsagar A & Mohler JL. Outcomes after radical retropubic prostatectomy. Urology 2003; 61: 412−416. | Article | PubMed |
29. McCullough AR. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001; 28: 613−627. | PubMed | ChemPort |
30. Walsh PC, Marschke P, Ricker D & Burnett AL. Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy. Urology 2000; 55: 62−67. | Article | PubMed | ChemPort |
31. Padma-Nathan H et al.. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 169 Suppl: 1402.
32. Montorsi F & Burnett AL. Erectile dysfunction after radical prostatectomy. BJU Int 2004; 93: 1−2. | Article | PubMed | ChemPort |
33. Montorsi F et al.. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45: 123−133. | Article | PubMed |
34. Van der Aa F, Joniau S, De Ridder D & Van Poppel H. Potency after unilateral nerve sparing surgery: a report on functional and oncological results of unilateral nerve sparing surgery. Prostate Cancer P D 2003; 6: 61−65. | Article | ChemPort |
35. Schnall MD et al.. Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 1991; 178: 797−802. | PubMed | ChemPort |
36. Geary ES & Stamey TA. Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng/ml. J Urol 1996; 156: 1056−1058. | Article | PubMed | ChemPort |
37. Daniels GF, Jr, McNeal JE & Stamey TA. Predictive value of controlateral biopsies in unilaterally palpable prostate cancer. J Urol 1992; 147: 870−874. | PubMed |
38. Catalona WJ. Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy. Urol Clin North Am 1990; 17: 819−822. | PubMed | ChemPort |
39. Ackerman DA et al.. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol 1993; 150: 1845−1850. | PubMed | ChemPort |
40. Scaletscky R et al.. Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J Urol 1994; 152: 129−131. | PubMed | ChemPort |
41. Partin AW et al.. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277: 1445−1451. | Article | PubMed | ISI | ChemPort |
42. Cheng L et al.. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol 2000; 18: 2862−2868. | PubMed | ISI | ChemPort |
43. Tigrani VS, Bhargava V, Shinohara K & Presti JC, Jr. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 1999; 54: 689−693. | Article | PubMed | ChemPort |
44. Alsikafi NF & Brendler CB. Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J Urol 1998; 159: 1281−1285. | Article | PubMed | ChemPort |
45. Park E, Dalkin B, Escobar C & Nagle RB. Site-specific positive margins at radical prostatectomy: assessing cancer-control benefits of wide excision of the neurovascualr bundle on a side with cancer on biopsy. BJU Int 2003; 91: 219−222. | Article | PubMed | ChemPort |
46. Sanwick JM, Dalkin BL & Nagle RB. Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery. Urology 1998; 52: 814−818. | Article | PubMed | ChemPort |
47. Graefen M et al.. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 2001; 165: 857−863. | Article | PubMed | ChemPort |
48. Huland H, Hubner D & Henke RP. Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, N0 prostatic carcinoma. Urology 1994; 44: 211−214. | Article | PubMed | ChemPort |
49. Walsh PC. Letter to editor. J Urol 2001; 165: 915. | Article | PubMed | ChemPort |
50. Holmes GF, Walsh PC, Pound CR & Epstein JI. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology 1999; 53: 752−756. | Article | PubMed | ChemPort |
51. Scardino PT & Kim ED. Rationale for and results of nerve grafting during radical prostatectomy. Urology 2001; 57: 301−307. | Article | PubMed | ChemPort |
52. Obek C et al.. Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology 1999; 54: 682−688. | Article | PubMed | ChemPort |
53. Shah O, Melamed J & Lepor H. Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol 2001; 165 (6, Part 1 of 2): 1943−1949. | Article | PubMed | ChemPort |
54. Goharderakhshan RZ et al.. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. Urology 2002; 59: 709−714. | Article | PubMed |
55. May F et al.. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 2001; 87: 66−69. | Article | PubMed | ChemPort |
56. Epstein JI. Evaluation of radical prostatectomy capsular margins of resection. The significance of margins designated as negative, closely approaching, and positive. Am J Surg Pathol 1990; 14: 626−632. | PubMed | ChemPort |
57. Cangiano TG et al.. Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. J Urol 1999; 162 (3, Part 1): 655−658. | Article | PubMed | ChemPort |
58. Sofer M, Hamilton-Nelson KL, Schlesselman JJ & Soloway MS. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol 2002; 20: 1853−1858. | Article | PubMed |
59. Walsh PC. Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 2001; 57: 1020−1024. | Article | PubMed | ChemPort |
60. Shah O, Robbins DA, Melamed J & Lepor H. The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J Urol 2003; 169: 2147−2152. | Article | PubMed |
61. McNeal JE et al.. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 1990; 14: 240−247. | PubMed | ChemPort |
62. Catalona WJ & Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 1990; 143: 538−543. | PubMed | ChemPort |
63. Epstein JI, Partin AW, Sauvageot J & Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996; 20: 286−291. | Article | PubMed | ISI | ChemPort |
64. Eastham JA et al.. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003; 170 (6, Part 1): 2292−2295. | Article | PubMed |
65. Rosen MA et al.. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 1992; 148 (2, Part 1): 331−337. | PubMed | ISI | ChemPort |
66. Ohori M et al.. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995; 154: 1818−1824. | Article | PubMed | ChemPort |
67. Wahle S et al.. Incidence of surgical margin involvement in various forms of radical prostatectomy. Urology 1990; 36: 23−26. | Article | PubMed | ChemPort |
68. Jones EC. Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension. J Urol 1990; 144: 89−93. | PubMed | ChemPort |
69. van den Ouden D, Bentvelsen FM, Boeve ER & Schroder FH. Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Br J Urol 1993; 72: 489−494. | PubMed | ChemPort |
70. Eggleston JC & Walsh PC. Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. J Urol 1985; 134: 1146−1148. | PubMed | ChemPort |
71. Epstein JI, Pizov G & Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582−3593. | PubMed | ChemPort |
72. Misop H, Partin AW, Chan DY & Walsh PC. An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. J Urol 2004; 171: 23−26. | Article | PubMed |
73. Smith RC, Partin AW, Epstein JI & Brendler CB. Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J Urol 1996; 156: 454−457. | Article | PubMed | ChemPort |
74. Soulie M et al.. Impact of a modified apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins: a comparative study in 212 patients. Urology 2001; 58: 217−221. | Article | PubMed | ChemPort |
75. Stamey TA et al.. Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol 1990; 143: 1166−1172. | PubMed | ChemPort |
76. Barocas DA et al.. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer? Urology 2001; 58: 746−751. | Article | PubMed | ChemPort |
77. Blute ML et al.. Pathologic classification of prostate carcinoma: the impact of margin status. Cancer 1998; 82: 902−908. | Article | PubMed | ChemPort |
78. Salomon L et al.. Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology 2003; 61: 386−390. | Article | PubMed |
79. Katz R et al.. Positive surgical margins in laparoscopic radical prostatectomy: the impact of apical dissection, bladder neck remodeling and nerve preservation. J Urol 2003; 169: 2049−2052. | Article | PubMed |
80. Roumeguere T et al.. Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches. World J Urol 2003; 20: 360−366. | PubMed |

Extra navigation

.

naturejobs

ADVERTISEMENT